Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.

MLA

Tan, Aaron C., et al. “Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 15, no. 12, Dec. 2020, pp. 1928–34. EBSCOhost, https://doi.org/10.1016/j.jtho.2020.08.011.

APA

Tan, A. C., Seet, A. O. L., Lai, G. G. Y., Lim, T. H., Lim, A. S. T., Tan, G. S., Takano, A., Tai, D. W. M., Tan, T. J. Y., Lam, J. Y. C., Ng, M. C. H., Tan, W. L., Ang, M.-K., Kanesvaran, R., Ng, Q. S., Jain, A., Rajasekaran, T., Lim, W.-T., Tan, E.-H., … Tan, D. S. W. (2020). Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 15(12), 1928–1934. https://doi.org/10.1016/j.jtho.2020.08.011

Chicago

Tan, Aaron C, Amanda O L Seet, Gillianne G Y Lai, Tse Hui Lim, Alvin S T Lim, Gek San Tan, Angela Takano, et al. 2020. “Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 15 (12): 1928–34. doi:10.1016/j.jtho.2020.08.011.